Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 10071-10080 of 13616

Page
per page
  1. Hesperadin
    A4118 Hesperadin
     1 Citation
    Target: Aurora Kinases
    Summary: Aurora B kinase inhibitor
      ≥25.85 mg/mL
  2. Ciprofibrate
    A4306 Ciprofibrate
    Summary: PPARα agonist
      insoluble in H2O; ≥10.85 mg/mL
  3. Rolipram
    A4328 Rolipram
    Target: Phosphodiesterases (PDEs)
    Summary: PDE4-inhibitor and an anti-inflammatory agent
      insoluble in H2O; ≥13 mg/mL
  4. 10-DAB (10-Deacetylbaccatin)
    A4395 10-DAB (10-Deacetylbaccatin)
    Summary: Precursor of antitumor compound Palitaxel and Docetaxel
      ≥22.25 mg/mL
  5. Amadacycline
    A3171 Amadacycline
    Summary: Tetracycline antibiotic
      ≥3.295 mg/mL
  6. CO-1686 (AVL-301)
    A3320 CO-1686 (AVL-301)
     1 Citation
    Target: EGFR
    Summary: EGFR inhibitor
      ≥27.8 mg/mL
  7. CP-809101
    A3330 CP-809101
    Summary: 5-HT2C receptor agonist
      Soluble in DMSO
  8. CZC24832
    A3340 CZC24832
    Summary: Selective PI3K-γ inhibitor
      insoluble in H2O; insoluble in EtOH; ≥6.07 mg/mL
  9. DOXO-EMCH
    A3372 DOXO-EMCH
    Summary: Prodrug of doxorubicin
      Soluble in DMSO
  10. Flavopiridol
    A3417 Flavopiridol
    Target: Cyclin-Dependent Kinases
    Summary: Pan-cdk inhibitor
      insoluble in H2O; ≥40.2 mg/mL

Items 10071-10080 of 13616

Page
per page